Page last updated: 2024-08-18

4,4'-dihydroxybiphenyl and salicylic acid

4,4'-dihydroxybiphenyl has been researched along with salicylic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Albert, DH; Augeri, DJ; Betebenner, D; Craig, R; Davidsen, SK; Fesik, SW; Guo, Y; Hajduk, PJ; Meadows, RP; Michaelides, M; Nettesheim, DG; Shuker, SB; Xu, L1
Bridewell, DJ; Ching, LM; Flanagan, JU; Fung, SP; Jamie, JF; Palmer, BD; Squire, CJ; Tijono, SM; Tomek, P; Wang, H1

Reviews

1 review(s) available for 4,4'-dihydroxybiphenyl and salicylic acid

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

2 other study(ies) available for 4,4'-dihydroxybiphenyl and salicylic acid

ArticleYear
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.
    Journal of medicinal chemistry, 2002, Dec-19, Volume: 45, Issue:26

    Topics: Animals; Biological Availability; Catalytic Domain; Hydroxamic Acids; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Models, Molecular; Naphthalenes; Protease Inhibitors; Protein Binding; Rats; Structure-Activity Relationship

2002
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
    Bioorganic & medicinal chemistry, 2013, Dec-15, Volume: 21, Issue:24

    Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Hydrazines; Immune System; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship

2013